FR289M - Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives. - Google Patents

Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.

Info

Publication number
FR289M
FR289M FR836770A FR836770A FR289M FR 289 M FR289 M FR 289M FR 836770 A FR836770 A FR 836770A FR 836770 A FR836770 A FR 836770A FR 289 M FR289 M FR 289M
Authority
FR
France
Prior art keywords
hypercholesterolemia
treatment
related conditions
medicinal product
thyronine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR836770A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of FR289M publication Critical patent/FR289M/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR836770A 1959-01-05 1960-08-25 Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives. Expired FR289M (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR814902
GB40059 1959-01-05

Publications (1)

Publication Number Publication Date
FR289M true FR289M (en) 1961-02-24

Family

ID=1341895

Family Applications (1)

Application Number Title Priority Date Filing Date
FR836770A Expired FR289M (en) 1959-01-05 1960-08-25 Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.

Country Status (1)

Country Link
FR (1) FR289M (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188351A2 (en) * 1985-01-18 1986-07-23 Smith Kline & French Laboratories Limited Chemical compounds
US5061798A (en) * 1985-01-18 1991-10-29 Smith Kline & French Laboratories, Ltd. Benzyl pyridyl and pyridazinyl compounds

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0188351A2 (en) * 1985-01-18 1986-07-23 Smith Kline & French Laboratories Limited Chemical compounds
EP0188351A3 (en) * 1985-01-18 1989-03-15 Smith Kline & French Laboratories Limited Chemical compounds
US4910305A (en) * 1985-01-18 1990-03-20 Smith Kline & French Laboratories Limited Pyridyl and pyridazinyl substituted thyronine compounds
US5061798A (en) * 1985-01-18 1991-10-29 Smith Kline & French Laboratories, Ltd. Benzyl pyridyl and pyridazinyl compounds

Similar Documents

Publication Publication Date Title
FR289M (en) Medicinal product for use in the treatment of hypercholesterolemia and related conditions, based on thyronine derivatives.
FI45660C (en) Process for the preparation of N-acyl derivatives of D-6-methyl and D-1,6-dimethyl-8-aminomethylergoline I for therapeutic use.
FR1315362A (en) Device for the treatment, by pressure, of strip work
FR1438M (en) New drug effective in the treatment of atherosclerosis.
NL181573C (en) DEVICE FOR TRANSFER AND TREATMENT OF TEXTILE THREADS.
FR1130M (en) Medicament based on 10 [1 ', 3'-dimethyl-pyrrolidly- (3') - methyl] -phenothiazine for the treatment of mental illness.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR1843M (en) Medicinal product based on amides of 1,4-benzodioxane-carboxylic acids.
FR1242M (en) Medicament, which can be used in particular for the treatment of fungal diseases, based on griseofulvin derivatives.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR2410M (en) Medicinal product based on oxazine derivative.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR128M (en) New galenic form of heparin derivatives used in the treatment of hemorrhoids.
FI47485C (en) A process for the preparation of indole-substituted amides suitable for therapeutic purposes of lysergic acid or 9,10-dihydrolysergic acid.
FR284M (en) Medicinal product based on 6 alpha-methyl-9 alpha-fluoro-11 beta, 17 alpha-dihydroxy-1,4-pregnadiene-3,20-dione for the treatment of amenorrhea.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR1180M (en) Medicinal product based on a derivative of uracyl, intended in particular for the treatment of hyperuricemia and hypercholesterolemia.
FR1222733A (en) Pharmaceutical Ampoule Box Easels
FR31M (en) New drug in particular for the treatment of arterial hypertension.
FR1162M (en) Medicinal product applicable in the therapy of hypertension.
FR2024M (en) Use of isoxazole derivatives for the treatment of mental illnesses and in particular of nervous breakdowns.
FR124M (en) New pharmaceutical composition for use in the treatment of hypertension and diuresis.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.